The clean auditor consent letter removes the immediate overhang from the change, but the company remains a development-stage OTC stock with no disclosed revenue or pipeline catalysts. Monitor the next periodic report (10-Q) for any auditor-related findings or going-concern language.
Price Chart
Executive Summary
CTT Pharmaceutical Holdings filed an 8-K with Item 4.01 (Change in Accountant), attaching a letter from predecessor auditor Holt & Patterson, LLC confirming it agrees with the company's prior disclosure regarding the auditor change. No disagreements, reportable conditions, or material weaknesses are disclosed. The filing is a procedural step to close out the auditor transition.
Key Facts
- Filed 8-K on October 9, 2026, reporting a change in certifying accountant (Item 4.01).
- Predecessor auditor Holt & Patterson, LLC provided a letter (Ex-16.1) agreeing with the company's disclosure in the prior 8-K dated October 2, 2026.
- No disagreements, adverse opinions, reportable conditions, or material weaknesses mentioned in the filing.
- Company trades on OTCQB under ticker CTTH and is a micro-cap pharmaceutical development-stage company.
Financial Impact
No financial figures disclosed; this is a procedural auditor-transition filing.
Risk Factors
- Auditor changes at micro-cap companies can signal undisclosed accounting issues; the absence of a 4.02 (non-reliance) is mildly positive but not conclusive.
- No financial data or business update in this filing — limited information for valuation.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001477932-26-006156 |
| Document: ctth_ex161.htm | 0001477932-26-006156 |
| Document: 0001477932-26-006156-index-headers.html | 0001477932-26-006156 |
| Document: 0001477932-26-006156-index.html | 0001477932-26-006156 |
| Document: 0001477932-26-006156.txt | 0001477932-26-006156 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 17d ago | 8-K | $0.0566 | awaiting T+60 | — | $0.0570 (+0.71%) |
Oct 7, 2026 19d ago | 8-K | $0.0566 | awaiting T+60 | — | $0.0570 (−0.71%) |
Aug 12, 2026 10w ago | 8-K | $0.0660 | awaiting T+60 | — | $0.0570 (−13.64%) |
Jul 24, 2026 13w ago | S-1/A | $0.0660 $0.0589 | ▲ +10.76% | ▲ +14.31% | $0.0570 (+13.64%) |
Jun 29, 2026 17w ago | S-1/A | $0.0750 $0.0485 | ▲ +35.33% | ▲ +38.38% | $0.0570 (+24.00%) |
Jun 16, 2026 18w ago | S-1/A | $0.0800 $0.0518 | ▲ +35.25% | ▲ +38.66% | $0.0570 (+28.75%) |
May 29, 2026 21w ago | S-1/A | $0.0720 $0.0570 | ▲ +20.83% | ▲ +22.02% | $0.0570 (+20.83%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers